Ilomastat

Overview

Ilomastat (GM6001) is a potent and broad spectrum matrix metalloprotease ( MMP ) inhibitor, inhibits MMPs ( IC 50 s, 1.5 nM for MMP-1 ; 1.1 nM for MMP-2 ; 1.9 nM for MMP-3 ; 0.5 nM for MMP-9 ), with a K i of 0.4 nM for human skin fibroblast collagenase ( MMP-1 ).

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > MMP

Product Information

• Catalog No.: HY-15768
• CAS No.: 142880-36-2
• Molecular Formula: C20H28N4O4
• Molecular Weight: 388.46
• Purity: 99.14%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (6.44 mM); Clear solution
• Availability: In-stock

Source

Original product source